Atlas Trials

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Clinical trial NCT01738347 · COMPLETED

Trial details

NCT number
NCT01738347
Sponsor
GE Healthcare
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsing-remitting Multiple Sclerosis (rrMS)
Start date
2013-04-01
Primary completion
2016-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.